Completed NA INTERVENTIONAL 2-arm NCT02291952

Development of Countermeasures Against Adverse Metabolic Effects of Shift Work

Sponsor: Brigham and Women's Hospital

Updated 7 times since 2017 Last updated: Mar 18, 2020 Started: Mar 19, 2015 Primary completion: Aug 29, 2018 Completion: Aug 29, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Circadian Dysregulation and is currently completed. Brigham and Women's Hospital leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2020 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Oct 2018 — Apr 2020 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

Jun 2018 — Oct 2018 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Data source: Brigham and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States